Kent County EMS Protocols
Updates
- 10.1.2021 Protocol App Update
- 9-30-2021 EMS MEDICATION ALERT - EPINEPHRINE PRELOAD KIT
- LSA EMResource Requirements Memo
- Optimizing Personal Protective Equipment During Crisis Capacity
- Metro Health CE Information
- First Responder Support
- MCA Application to Adopt Naloxone Leave Behind Optional Protocol
- Naloxone Medication Kit Contents And Distribution Procedure (Optional)
- Naloxone Leave Behind Protocol (Optional)
- Active Assailant Policy
- Electronic Records & EMS Information System
- 8-29. Electronic Records & EMS Information System
- 7-15 WMRMCC Patient Care Record New Draft 2.23.2021
- WMRMCC Field Notes
- 11-1. Critical Care Program Policy
- 11-2. Critical Care - General
- 11-3. Critical Care Continuing Education Requirements
- 11-4. Critical Care Medication Administration
- 9.29 WMRMCC Ketamine 06-09-2021 v1
- KCEMS Update July 10, 2020 1400
- KCEMS COVID-19 Update June 9, 2020 1600
- KCEMS COVID-19 Update May 28, 2020 - 1700
- KCEMS COVID-19 Update May 22, 2020 - 1100
- KCEMS COVID-19 Update May 7, 2020 - 1500
- KCEMS COVID-19 Update May 1, 2020 - 1300
- KCEMS COVID-19 Update April 15, 2020 - 1530
- KCEMS COVID-19 Update April 14, 2020 - 1730
- KCEMS COVID-19 Update April 13, 2020 - 1730
- KCEMS COVID-19 Update April 10, 2020 - 1600
- KCEMS COVID-19 Update April 9, 2020 - 1700
- KCEMS COVID-19 Update April 8, 2020 - 1700
- KCEMS COVID-19 Update April 7, 2020 - 1700
- KCEMS COVID-19 Update April 6, 2020 - 1700
- KCEMS COVID-19 Update April 2, 2020 - 1730
- KCEMS COVID-19 Update April 1, 2020 - 1700
- KCEMS COVID-19 Update March 30, 2020 - 1730
- KCEMS COVID-19 Update March 28, 2020 - 0700
- KCEMS COVID-19 Update March 26, 2020 - 1700
- KCEMS COVID-19 Update March 25, 2020 - 1730
- KCEMS COVID-19 Update March 24, 2020 - 1700
- KCEMS COVID-19 Update March 23, 2020 - 1700
- KCEMS COVID-19 Update March 20, 2020 - 1700
- KCEMS COVID-19 Update March 19, 2020 - 1700
- KCEMS COVID-19 Update March 18, 2020 - 1630
- KCEMS COVID-19 Update March 17, 2020 - 1700
- KCEMS COVID-19 Update March 17, 2020 - 1030
- KCEMS COVID-19 Update March 16, 2020 - 1700
- KCEMS COVID-19 Update March 16, 2020 - 1200
COVID Testing Information
DRAFT Protocols
Naloxone Leave Behind Protocols
KCEMS COVID Updates
KCEMS Protocols
- 1-1. General Pre-Hospital Care
- 1-2. Abdominal Pain (Non-Traumatic)
- 1-3. Nausea & Vomiting
- 1-4. Syncope
- 1-5. Shock
- 1-6. Anaphylaxis / Allergic Reaction
- 1-6a. MFR & Basic EMT-Epinephrine Study
- 1-7. Adrenal Crisis
- 1-8. Behavioral Health Emergencies
- 1-9. Return of Spontaneous Circulation
- 2-1. Trauma Destination Protocol
- 2-2. General Trauma
- 2-3. Burns
- 2-4. General Crush Injury
- 2-5. Soft Tissue and Orthopedic Injuries
- 2-6. Spinal Injury Assessment
- 2-7. Traumatic Arrest
- 2-8. Drowning / Submersion Injury
- 2-9. Poisoning / Overdose / Environmental Exposure
- 2-10. Heat Emergencies
- 2-11. Hypothermia / Frostbite
- 2-12. Hypothermia Cardiac Arrest
- 3-1. Altered Mental Status
- 3-2. Stroke or Suspected Stroke
- 3-3. Respiratory Distress
- 3-4. Seizures
- 3-5. Sepsis
- 3-6. Excited Delirium
- 3-6a. Excited Delirium - Addendum
- 4-1. Pediatric Medication Emergency Dosing and Intervention Cards
- 4-2. Obstetrical Emergencies
- 4-3. Neonatal Assessment and Resuscitation
- 4-4. Pediatric Altered Mental Status
- 4-5. Pediatric Respiratory Distress, Failure or Arrest
- 4-6. Pediatric Fever
- 4-7. Pediatric Seizures
- 4-8. Safe Transportation of Children in Ambulances
- 5-1. Cardiac Arrest - General
- 5-2. Bradycardia
- 5-3. Tachycardia
- 5-4. Pulmonary Edema / CHF
- 5-5. Chest Pain / Acute Coronary Syndrome
- 5-6. Nitroglycerin Drip Supplement
- 7-1. 12-Lead ECG
- 7-2. Abuse and Neglect (Suspected)
- 7-3. Crime Scene Management
- 7-4. Contaminated Patient
- 7-5. CPAP / BiPAP Administration
- 7-6. Dead on Scene
- 7-7. Do-Not-Resuscitate
- 7-8. Electrical Therapy
- 7-9. Emergency Airway
- 7-9(S). Nasal Intubation Procedure
- 7-9(S2). Emergency Airway (Supplement) LMA Supreme ®
- 7-10. Injured Athlete & Helmet Removal
- 7-11. Impedance Threshold Device (ITD)
- 7-12. Oxygen Administration
- 7-13. Pain Management
- 7-14. Patient Assessment
- 7-15. Patient Care Record, Electronic Documentation & EMS Information System
- 7-16. Patient Restraint
- 7-17. Patient Sedation
- 7-18. Pleural Decompression
- 7-19. Refusal of Care; Adult and Minor
- 7-20. Spinal Precautions
- 7-21. Termination of Resuscitation
- 7-22. Tourniquet Application
- 7-23. Vascular Access & IV Fluid Therapy
- 7-24. End-Tidal Carbon Dioxide Monitoring
- 7-25. Michigan Physician Orders for Scope of Treatment (MI-POST)
- 7-26. High Performance CPR (HP-CPR)
- 7-26(S). Cardiocerebral Resuscitation (CCR) Supplement to High Performance CPR (HP-CPR)
- 7-27. Blood Product Administration
- 8-1. Cancellation / Downgrade of Call Policy
- 8-2. Use of Emergency Lights and Sirens During Transport
- 8-2a. Use of Emergency Lights and Sirens During Transport – Addendum
- 8-3. Destination and Diversion Policy
- 8-4. High-Risk Delivery Transport Guidelines
- 8-5. Intercept Policy
- 8-6. Dispatch
- 8-7. Lights and Sirens Response to the Scene
- 8-8. Patient Prioritization Protocol
- 8-9. Helicopter Utilization
- 8-10. Communicable Disease
- 8-11. Infection Control
- 8-11-KC. Infection Control (KCEMS)
- 8-12. Communications Failure
- 8-13. Waiver of EMS Patient Side Communication Capabilities
- 8-14. Health Insurance Portability Accountability Act
- 8-15. Inter-Facility Patient Transfers and Critical Care Patient Transports
- 8-15a. Interfacility Patient Transfers - Addendum
- 8-15a-RS. Interfacility Patient Transfers - Addendum (Region Specific)
- 8-16. Licensure Level Requirement of Attendant during Transport
- 8-17. Medical Control Privileges
- 8-17a. MCA Privileges Policy - Addendum
- 8-18. Responsibilities of the Participants in the Medical Control Authority System
- 8-19. Physician on Scene
- 8-20. Protocol Deviation
- 8-21. Violent / Chemical / Hazardous Scene
- 8-22. Determination of Death, Death in an Ambulance and Transport of a Body
- 8-23. Safe Delivery of Newborns
- 8-24. Complaint Investigation & Resolution
- 8-25. Disciplinary Action Appeal
- 8-26. Due Process and Disciplinary Procedure
- 8-27. Quality Improvement Policy
- 8-28. Incident Classification
- 8-29. Physician Signatures and Medical Control Contact Policy
- 8-30. Medical Control Privileges Testing Policy and Procedure
- 8-31. Alternative Transport Policy
- 8-32. ICD and Pacemaker Deactivation Policy
- 8-33. Left Ventricular Assist Devices
- 8-34. Medical Direction Override Policy
- 8-35. Treatment and Transport of a Minor Patient Policy
- 8-36. Public Access Defibrillator Policy
- 8-37. Pediatric Policy
- 8-38. Medical Evaluation and Rehab of Public Safety Personnel Policy
- 8-39. Lift Assist Protocol
- 8-40. MABEES Epinephrine Kit Contents and Exchange Procedure
- 8-41. STEMI and Stroke Alert Policy
- 8-42. Communications Policy
- 8-43. System Participation Criteria for Adult and Pediatric Trauma Facilities
- 8-44. Medical Priority Dispatch Policy (KCEMS)
- 8-44a. Medical First Responder Unit Assignment for Echo Calls (KCEMS)
- 8-45. CPAP Breathing Circuit Exchange Policy (KCEMS)
- 8-46. Epi-Pen Supply and Restocking Administrative Procedure (KCEMS)
- 8-47. Transport of an Apparently Intoxicated Patient Policy (KCEMS)
- 8-48. Identification Card Policy (KCEMS)
- 8-49. Notification of Medical Director Policy (KCEMS)
- 8-50. Request for Ambulance Service Policy (KCEMS)
- 8-51. Medical First Responder Unit Assignment for ECHO Calls Policy
- 8-55. WMRMCC - Emergent Interfacility Transfer Policy
- 8-56. Interfacility Transfer Mutual Aid Policy
- 8-57. EMResource® Utilization Policy
- 8-58. EMTrack® Utilization Policy
- 9-1. Medication Administration
- 9-1A. Medication Administration Addendum
- 9-2. Medication Substitution
- 9-3. Medication Shortage
- 9-4. Intranasal Medication Administration
- 9-5. Field Drug Box and IV Kits
- 9-6. Pharmacy, Drug Box and IV Supply Exchange Procedure
- 9-7. Epinephrine Auto-Injector Procedure
- 9-8. Nebulized Bronchodilators
- 9-9. Naloxone Administration
- 9-10. 2-Pam Chloride / DuoDote
- 9-11. Acetaminophen
- 9-12. Adenosine
- 9-13. Albuterol
- 9-14. Amiodarone
- 9-15. Acetylsalicylic Acid (Aspirin)
- 9-16. Atropine
- 9-17. Calcium Chloride
- 9-18. Dextrose
- 9-19. Diazepam
- 9-20. Diphenhydramine
- 9-21. Dopamine
- 9-22. Epinephrine
- 9-23. Fentanyl
- 9-24. Glucagon
- 9-25. Hydromorphone
- 9-26. Cyanokit
- 9-27. Ibuprofen
- 9-28. Ipratropium Bromide
- 9-29. Ketamine
- 9-30. Ketorolac
- 9-31. Lorazepam
- 9-32. Lidocaine
- 9-33. Magnesium Sulfate
- 9-34. Methylprednisolone
- 9-35. Midazolam
- 9-36. Morphine
- 9-37. Naloxone
- 9-38. Nitroglycerin
- 9-39. Ondansetron
- 9-40. Prednisone
- 9-41. Sodium Bicarbonate
- 9-42. Tetracaine Hydrochloride
- 9-43. Tranexamic Acid
- 10-1. General CBRNE Identification of Agents
- 10-2. Chemical Exposure
- 10-3. Nerve Agent/Organophosphate Pesticide Exposure Treatment
- 10-4. CHEMPACK/MEDDRUN
- 10-5. Cyanide Exposure
- 10-6. Mass Casualty Incidents
- 10-7. Pre-Hospital (EMS) MCA Mutual Aid Agreement
- 10-8. EMS Immunization & TB Testing
- 10-9. Suspected Pandemic Influenza
- 10-10. Special Pathogen Response Network (SPRN) Transport and Destination Guidelines
- 10-11. Special Pathogen Response Network (SPRN) Patient Containment Algorithm
- 10-12. Special Pathogen Response Network (SPRN) Transport Supplies
- 10-13. Special Pathogen Response Network (SPRN) Transport Procedure
- 10-14. Special Pathogen Response Network (SPRN) Patient Care During Transport of Suspected Highly Infectious Agent
- 10-15. Special Pathogen Response Network (SPRN) Ambulance Cleaning and Disinfection
- 10-16. Special Pathogen Response Network (SPRN) Medical Isolation Transport Device
- 10-17. Special Pathogen Response Network (SPRN) Team Selection Procedure
- 10-21. Cardiac Arrest in a Patient with Suspected COVID-19 Crisis Standard of Care
- 11-1. TANDEM365 Continuity Planning
- 11-2. General Treatment
- 11-3. TANDEM365 Physician Oversight
- 11-4. Congestive Heart Failure
- 11-5. Dehydration
- 11-6. Fever
- 11-7. Gastrointestinal Complaints
- 11-8. Mild/Moderate Pain
- 11-9. Respiratory Distress
- 11-10. Upper Respiratory Infection Symptoms
- 11-11. Urinary Complaints
- 11-12. Specimen Collection Procedure
- 14-01. Privileging and Participating Facilities Release During COVID-19 Response
- 14-04. Coronavirus Disease (COVID-19)
- 14-06. Clinical Treatment for Patient with Suspected or Confirmed COVID-19
- 14-11. Immunization Support During COVID-19 Outbreak
- 14-13. Monoclonal Antibody Administration
- 14-13a. Monoclonal Antibody Bamlanivimab Order Form for Adults Patients ≥ 12 Years Old
- 14-14. Metered Dose Inhaler - COVID-19 Protocol
1. General Treatment Protocols
2. Trauma and Environmental Emergencies
3. Adult Treatment Protocols
4. Obstetrics and Pediatrics
5. Adult Cardiac Protocols
6. Pediatric Cardiac Protocols
7. Procedures
8. System Protocols
9. Medications
10. Special Operations
11. Community Paramedicine
14. COVID-19 Protocols
MI-MEDIC Cards
- Cover Page
- Instructions
- Pediatric Quick Guide
- 3-5 kg (6-12 lbs) / 0-2 Months (Gray)
- 6-7 kg (13-16 lbs) / 3-6 Months (Pink)
- 8-9 kg (17-20 lbs) / 7-10 Months (Red)
- 10-11 kg (21-25 lbs) / 11-18 Months (Purple)
- 12-14 kg (26-31 lbs) / 19-35 Months (Yellow)
- 15-18 kg (32-40 lbs) / 3-4 Years (White)
- 19-22 kg (41-51 lbs) / 5-6 Years (Blue)
- 24-28 kg (52-64 lbs) / 7-9 Years (Orange)
- 30-36 kg (65-79 lbs) / 10-12 Years (Green)
- Adult / >14 Years (Black) [Temporarily Removed]
- About MI-MEDIC
KCEMS Disaster Plan
- WMRMCC Regional MCI Plan
- MCI Guidebook: Cover Page
- MCI Guidebook: Disaster Paradigm
- MCI Guidebook: METHANE+ Situation Report
- MCI Guidebook: First Arriving Actions
- MCI Guidebook: Suggested Communication Channels for Large Incidents
- MCI Guidebook: Medical Branch Command
- MCI Guidebook: Triage Supervisor
- MCI Guidebook: Treatment Supervisor
- MCI Guidebook: Staging Supervisor
- MCI Guidebook: Transport Supervisor
- MCI Guidebook: Resource Page
- EMS Dispatch Disaster/MCI Task Book
- MCI Guidebook: Cover Page
- MCI Guidebook: Disaster Paradigm
- MCI Guidebook: METHANE+ Situation Report
- MCI Guidebook: First Arriving Actions
- MCI Guidebook: Suggested Communication Channels for Large Incidents
- MCI Guidebook: Medical Branch Command
- MCI Guidebook: Triage Supervisor
- MCI Guidebook: Treatment Supervisor
- MCI Guidebook: Staging Supervisor
- MCI Guidebook: Transport Supervisor
- MCI Guidebook: Resource Page
- EMS Dispatch Disaster/MCI Task Book
- GRFIA HRT Notification Procedure
WMRMCC Regional MCI plan
MCI Guidebook
MCI Guidebook
KCEMS Data Dashboards
- 2021 KCEMS Quality Improvement Dashboard
- Kent County 911 Call Volume
- 2020 KCEMS Quality Improvement Dashboard
- 2019 Resuscitation Dashboard
- 2020 Resuscitation Dashboard
- Kent County Stroke Statistics
- 2020 Stroke Dashboard
KCEMS Resources
- LSA Reference Document
- MDHHS EO's & Directives Quick Sheet for EMS
- MIS-C EMS Tip Sheet
- First Responder Provider Request for HIV and/or Hepatitis B Testing of Emergency Patient
- Supporting First Responders During COVID-19
- KCEMS 2020 Annual Report
- EMS mAb Presentation
- Fact Sheet for Health Care Providers Emergency Use Authorization (EUA) of Bamlanivimab
- Fact Sheet for Patients, Parents and Caregivers Emergency Use Authorization (EUA) of Bamlanivimab for Coronavirus Disease 2019 (COVID-19)
- Monoclonal Antibody Bamlanivimab Order Form for Adults Patients ≥ 18 Years Old
- Bamlanivimab Pocket Resource Card
- Useful Websites and Document Links for Information on COVID-19 Vaccines
- The Ambulance Child Restraint (ACR) For Safe Transport of Children in Ambulances
- HDVCH EMS and ED Care for Child With Congenital Heart Disease
- Care of the Pediatric Congenital Heart Patient
- Submit a Report to the MCA
- Front Matter
- Table of Contents
- Introduction and Safety
- System Components
- Battery Compatibility
- Setting Up the Pump
- Operational Overview
- Preparing the Pump and IV Sets
- Programming the Pump
- Pump Operation
- Alarms
- Cleaning and Storage
- Compatible IV Sets
- Accessories
- APPENDIX A - Specifications
- APPENDIX B - Flow Rate Accuracy
- APPENDIX C - Bolus Accuracy
- APPENDIX D - Downstream Occlusion
- APPENDIX E - Electromagnetic Compatibility
- APPENDIX F - Low / Very Low Battery Tutorial
- APPENDIX G - Icons
- APPENDIX H - Spectrum Default Settings
- Metro IV Pump Quick Reference Guide
- Glasgow Coma Scale ‐ Adults
- Pediatric Glasgow Coma Scale
- DNR Flow Chart
- Acetaminophen Dosing Table
- Ibuprofen Dosing Table
- VAD Community Training Slides
- Cover Sheet
- Questions and Answers for Ventricular Assist Device
- Color Coding System
- Patient Management for VADs
- HeartMate III with Pocket Controllers
- HeartMate II
- HeartWare Ventricular Assist System
- Jarvik 2000 VAS
- Title Page — Total Artificial Heart
- Patient Management for TAHs
- Questions and Answers for Total Artificial Heart
- Total Artificial Heart Freedom Driver System
Education
BAM
Sigma Spectrum Operator's Manual
Ventricular Assist Devices
KCEMS Memos
- December 9th, 2020: Culture of Safety and PPE Compliance (All LSA's and EMS Providers)
- January 31, 2019: AMA/Refusal Process When ALS Skills Are Performed (Life Support Agencies and Providers)
- January 31, 2019: AMA/Refusal Process When ALS Skills Are Performed (Medical Control Physicians and Emergency Department Staff)
- January 31, 2019: Scope of Practice
- December 14, 2018: Early Transport of Refractory VF/Pulseless VT
- December 14, 2018: Extended Scene Times for Patients with ROSC
- December 14, 2018: Ketamine Usage in Patients Over 65
KCEMS Newsletters
- September 2021
- August 2021
- June 2021
- December 2020
- May 2021
- October 2020
- September 2020
- April 2021
- August 2020
- July 2020
- June 2020
- May 2020
- February 2020
- January 2020: Protocol Improvements Edition
- March 2021
- January 2020
- December 2019
- November 2019
- September 2019
- April / May 2019
- February 2019
- January 2019
- December 2018
- November 2018
- June 2018: Protocol Update Edition
- June 2018: Prehospital Protocol Update Edition
- February 2021 Newsletter - Pediatric Edition
- June 2018: Hospital Protocol Update Edition
- May 2018
- April 2018
- February 2018
- New Year 2021
- February 2021
Last updated: 2021-10-11